II 

109TH CONGRESS 

2D SESSION S. 2560 

To reauthorize the Office of National Drug Control Policy. 

IN THE SENATE OF THE UNITED STATES 

APRIL 6, 2006 

Mr. SPECTER (for himself, Mr. BIDEN, Mr. HATCH, Mr. GRASSLEY, and Mr. 

LEVIN) introduced the following bill; which was read twice and referred 

to the Committee on the Judiciary 

A BILL 

To reauthorize the Office of National Drug Control Policy. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE, REFERENCE, AND TABLE OF 

4 CONTENTS. 

5 (a) SHORT TITLE.—This Act may be cited as the 

6 ‘‘Office of National Drug Control Policy Reauthorization 

7 Act of 2006’’. 

8 (b) AMENDMENT OF OFFICE OF NATIONAL DRUG

9 CONTROL POLICY REAUTHORIZATION ACT OF 1998.—Ex10 cept as otherwise expressly provided, whenever in this Act 

11 an amendment or repeal is expressed in terms of an 


ccoleman on PROD1PC71 with BILLS
2 

•S 2560 IS

1 amendment to, or repeal of, a section or other provision, 

2 the reference shall be considered to be made to a section 

3 or other provision of the Office of National Drug Control 

4 Policy Reauthorization Act of 1998 (Public Law 105–277; 

5 21 U.S.C. 1701 et seq.). 

6 (c) TABLE OF CONTENTS.—The table of contents for 

7 this Act is as follows: 

Sec. 1. Short title, reference, and table of contents. 

TITLE I—ORGANIZATION OF OFFICE OF NATIONAL DRUG 

CONTROL POLICY AND ROLES AND RESPONSIBILITIES 

Sec. 101. Amendments to definitions. 

Sec. 102. Establishment of the Office of National Drug Control Policy. 

Sec. 103. Appointment and responsibilities of the Director. 

Sec. 104. Amendments to ensure coordination with other agencies. 

TITLE II—THE NATIONAL DRUG CONTROL STRATEGY 

Sec. 201. Annual preparation and submission of National Drug Control Strategy. 

Sec. 202. Performance measurements. 

Sec. 203. Annual report requirement. 

TITLE III—HIGH INTENSITY DRUG TRAFFICKING AREAS 

Sec. 301. High Intensity Drug Trafficking Areas Program. 

Sec. 302. Funding for certain high intensity drug trafficking areas. 

Sec. 303. Assessment. 

TITLE IV—TECHNOLOGY 

Sec. 401. Counterdrug Technology Assessment Center. 

TITLE V—REAUTHORIZATION AND IMPROVEMENT OF THE 

NATIONAL ANTI-DRUG MEDIA CAMPAIGN 

Sec. 501. Short title. 

Sec. 502. Purposes of the National Youth Anti-Drug Media Campaign. 

Sec. 503. Roles and responsibilities of the Director, the Partnership for a 

Drug-Free America, and a media buying contractor. 

Sec. 504. Responsible use of Federal funds for the National Youth Anti-Drug 

Media Campaign. 

Sec. 505. Authorization for National Youth Anti-Drug Media Campaign. 

TITLE VI—AUTHORIZATIONS AND EXTENSION OF TERMINATION 

DATE 

Sec. 601. Authorization of appropriations. 

Sec. 602. Extension of termination date. 


ccoleman on PROD1PC71 with BILLS
3 

•S 2560 IS

TITLE VII—ANTI-DOPING AGENCY 

Sec. 701. Designation of United States Anti-Doping Agency. 

Sec. 702. Records, audit, and report. 

Sec. 703. Authorization of appropriations. 

TITLE VIII—DRUG-FREE COMMUNITIES 

Sec. 801. Reauthorization. 

Sec. 802. Suspension of grants. 

Sec. 803. Grant award increase. 

Sec. 804. Prohibition on additional eligibility criteria. 

Sec. 805. Supplemental grants for coalitions. 

Sec. 806. National Community Antidrug Coalition Institute. 

Sec. 807. Contracting requirement. 

TITLE IX—NATIONAL GUARD COUNTERDRUG SCHOOLS 

Sec. 901. National Guard Counterdrug Schools. 

TITLE X—MISCELLANEOUS PROVISIONS 

Sec. 1001. Repeals. 

Sec. 1002. Controlled Substances Act amendments. 

Sec. 1003. Report on intelligence sharing. 

Sec. 1004. Requirement for South American heroin strategy. 

Sec. 1005. Model Acts. 

1 TITLE I—ORGANIZATION OF OF2 FICE OF NATIONAL DRUG 

3 CONTROL POLICY AND ROLES 

4 AND RESPONSIBILITIES 

5 SEC. 101. AMENDMENTS TO DEFINITIONS. 

6 (a) DEMAND REDUCTION.—Section 702(1) is amend7 ed— 

8 (1) in subparagraph (F), by striking ‘‘and’’ 

9 after the semicolon; and 

10 (2) in subparagraph (G), by striking the period 

11 and inserting ‘‘; and’’; and 

12 (3) by adding at the end the following: 


ccoleman on PROD1PC71 with BILLS
4 

•S 2560 IS

1 ‘‘(H) international drug abuse education, 

2 prevention, treatment, research, rehabilitation 

3 activities, and interventions for drug abuse and 

4 dependence.’’. 

5 (b) OFFICE.—Section 702(9) is amended by striking 

6 ‘‘implicates’’ and inserting ‘‘indicates’’. 

7 (c) STATE AND LOCAL AFFAIRS.—Paragraph (10) of 

8 section 702 is amended to read as follows: 

9 ‘‘(10) STATE AND LOCAL AFFAIRS.—The term 

10 ‘State and local affairs’ means domestic activities 

11 conducted by a National Drug Control Program 

12 agency that are intended to reduce the availability 

13 and use of illegal drugs, including— 

14 ‘‘(A) coordination and enhancement of 

15 Federal, State, and local law enforcement drug 

16 control efforts; 

17 ‘‘(B) coordination and enhancement of ef18 forts among National Drug Control Program 

19 agencies and State and local demand reduction 

20 and supply reduction agencies; 

21 ‘‘(C) coordination and enhancement of 

22 Federal, State, and local law enforcement initia23 tives to gather, analyze, and disseminate infor24 mation and intelligence relating to drug control 

25 among domestic law enforcement agencies; and 


ccoleman on PROD1PC71 with BILLS
5 

•S 2560 IS

1 ‘‘(D) other coordinated and joint initiatives 

2 among Federal, State, and local agencies to 

3 promote comprehensive drug control strategies 

4 designed to reduce the demand for, and the 

5 availability of, illegal drugs.’’. 

6 (d) SUPPLY REDUCTION.—Section 702(11) is 

7 amended to read as follows: 

8 ‘‘(11) SUPPLY REDUCTION.—The term ‘supply 

9 reduction’ means any activity or program conducted 

10 by a National Drug Control Program agency that is 

11 intended to reduce the availability or use of illegal 

12 drugs in the United States or abroad, including— 

13 ‘‘(A) activities to control international traf14 ficking in, and availability of, illegal drugs, in15 cluding— 

16 ‘‘(i) accurate assessment and moni17 toring of international drug production and 

18 interdiction programs and policies; and 

19 ‘‘(ii) coordination and promotion of 

20 compliance with international treaties re21 lating to the production, transportation, or 

22 interdiction of illegal drugs; 

23 ‘‘(B) activities to conduct and promote 

24 international law enforcement programs and 

25 policies to reduce the supply of drugs; and 


ccoleman on PROD1PC71 with BILLS
6 

•S 2560 IS

1 ‘‘(C) activities to facilitate and enhance the 

2 sharing of domestic and foreign intelligence in3 formation among National Drug Control Pro4 gram agencies, relating to the production and 

5 trafficking of drugs in the United States and in 

6 foreign countries.’’. 

7 (e) DEFINITION OF APPROPRIATE CONGRESSIONAL

8 COMMITTEES.—Section 702 is amended by adding at the 

9 end the following: 

10 ‘‘(12) APPROPRIATE CONGRESSIONAL COMMIT11 TEES.—Except where otherwise provided, the term 

12 ‘appropriate congressional committees’ means the 

13 Committee on the Judiciary, the Committee on Ap14 propriations, and the Caucus on International Nar15 cotics Control of the Senate and the Committee on 

16 Government Reform, the Committee on the Judici17 ary, and the Committee on Appropriations of the 

18 House of Representatives.’’. 

19 SEC. 102. ESTABLISHMENT OF THE OFFICE OF NATIONAL 

20 DRUG CONTROL POLICY. 

21 (a) RESPONSIBILITIES.—Section 703(a) is amended 

22 to read as follows: 

23 ‘‘(a) ESTABLISHMENT OF OFFICE.—There is estab24 lished in the Executive Office of the President an Office 

25 of National Drug Control Policy, which shall— 


ccoleman on PROD1PC71 with BILLS
7 

•S 2560 IS

1 ‘‘(1) develop national drug control policy; 

2 ‘‘(2) coordinate and oversee the implementation 

3 of the national drug control policy; 

4 ‘‘(3) assess and certify the adequacy of Na5 tional Drug Control Programs and the budget for 

6 those programs; 

7 ‘‘(4) evaluate the effectiveness of National Drug 

8 Control Program agencies’ programs; and 

9 ‘‘(5) develop specific goals and performance 

10 measurements needed to assess the effectiveness 

11 of— 

12 ‘‘(A) the national drug control policy; and 

13 ‘‘(B) the programs of the National Drug 

14 Control Program agencies.’’. 

15 (b) POSITIONS.—Section 703(b) is amended to read 

16 as follows: 

17 ‘‘(b) DIRECTOR OF NATIONAL DRUG CONTROL POL18 ICY AND DEPUTY DIRECTORS.— 

19 ‘‘(1) DIRECTOR.—There shall be a Director of 

20 National Drug Control Policy who shall head the Of21 fice (referred to in this Act as the ‘Director’). 

22 ‘‘(2) DEPUTY DIRECTOR.—There shall be a 

23 Deputy Director of National Drug Control Policy 

24 who shall report directly to the Director (referred to 

25 in this Act as the ‘Deputy Director’). 


ccoleman on PROD1PC71 with BILLS
8 

•S 2560 IS

1 ‘‘(3) OTHER DEPUTY DIRECTORS.— 

2 ‘‘(A) IN GENERAL.—There shall be a Dep3 uty Director for Demand Reduction, a Deputy 

4 Director for Supply Reduction, and a Deputy 

5 Director for State and Local Affairs. 

6 ‘‘(B) REPORTING.—The Deputy Director 

7 for Demand Reduction, the Deputy Director for 

8 Supply Reduction, and the Deputy Director for 

9 State and Local Affairs shall report directly to 

10 the Deputy Director of the Office of National 

11 Drug Control Policy. 

12 ‘‘(C) DEPUTY DIRECTOR FOR DEMAND RE13 DUCTION.—The Deputy Director for Demand 

14 Reduction shall be responsible for the activi15 ties— 

16 ‘‘(i) in subparagraphs (A) through 

17 (H) of section 702(l); and 

18 ‘‘(ii) in section 709, the National 

19 Youth Anti-Drug Media Campaign Act. 

20 ‘‘(D) DEPUTY DIRECTOR FOR SUPPLY RE21 DUCTION.—The Deputy Director for Supply 

22 Reduction shall be responsible for the activities 

23 in subparagraphs (A) through (C) in section 

24 702(11). 


ccoleman on PROD1PC71 with BILLS
9 

•S 2560 IS

1 ‘‘(E) DEPUTY DIRECTOR FOR STATE AND

2 LOCAL AFFAIRS.—The Deputy Director for 

3 State and Local Affairs shall be responsible for 

4 the activities— 

5 ‘‘(i) in subparagraphs (A) through 

6 (D) of section 702(10); 

7 ‘‘(ii) in section 707, the High Inten8 sity Drug Trafficking Areas Program; and 

9 ‘‘(iii) in section 708, the Counterdrug 

10 Technology Assessment Center.’’. 

11 SEC. 103. APPOINTMENT AND RESPONSIBILITIES OF THE 

12 DIRECTOR. 

13 (a) SUCCESSION.—Section 704(a) is amended by 

14 amending paragraph (3) to read as follows: 

15 ‘‘(3) ACTING DIRECTOR.—If the Director dies, 

16 resigns, or is otherwise unable to perform the func17 tions and duties of the office, the Deputy Director 

18 shall perform the functions and duties of the Direc19 tor temporarily in an acting capacity pursuant to 

20 subchapter III of chapter 33 of title 5, United 

21 States Code.’’. 

22 (b) RESPONSIBILITIES.—Section 704(b) is amend23 ed— 

24 (1) in paragraph (4), by striking ‘‘Federal de25 partments and agencies engaged in drug enforceVerDate Aug 31 2005 02:23 Apr 08, 2006 Jkt 049196 PO 00000 Frm 00009 Fmt 6652 Sfmt 6201 E:\BILLS\S2560.IS S2560

ccoleman on PROD1PC71 with BILLS
10 

•S 2560 IS

1 ment’’ and inserting ‘‘National Drug Control Pro2 gram agencies’’; 

3 (2) in paragraph (7), by inserting after ‘‘Presi4 dent’’ the following: ‘‘and the appropriate congres5 sional committees’’; 

6 (3) in paragraph (13), by striking ‘‘(beginning 

7 in 1999)’’; 

8 (4) by striking paragraph (14) and inserting 

9 the following: 

10 ‘‘(14) shall submit to the appropriate congres11 sional committees on an annual basis, not later than 

12 60 days after the date of the last day of the applica13 ble period, a summary of— 

14 ‘‘(A) each of the evaluations received by 

15 the Director under paragraph (13); and 

16 ‘‘(B) the progress of each National Drug 

17 Control Program agency toward the drug con18 trol program goals of the agency using the per19 formance measures for the agency developed 

20 under section 706(c);’’; 

21 (5) in paragraph (15), by striking subpara22 graph (C) and inserting the following: 

23 ‘‘(C) supporting the substance abuse infor24 mation clearinghouse administered by the Ad25 ministrator of the Substance Abuse and Mental 


ccoleman on PROD1PC71 with BILLS
11 

•S 2560 IS

1 Health Services Administration and established 

2 in section 501(d)(16) of the Public Health 

3 Service Act by— 

4 ‘‘(i) encouraging all National Drug 

5 Control Program agencies to provide all 

6 appropriate and relevant information; and 

7 ‘‘(ii) supporting the dissemination of 

8 information to all interested entities;’’; and 

9 (6) by inserting at the end the following: 

10 ‘‘(16) shall coordinate with the private sector to 

11 promote private research and development of medi12 cations to treat addiction; 

13 ‘‘(17) shall seek the support and commitment of 

14 State and local officials in the formulation and im15 plementation of the National Drug Control Strategy; 

16 ‘‘(18) shall monitor and evaluate the allocation 

17 of resources among Federal law enforcement agen18 cies in response to significant local and regional 

19 drug trafficking and production threats; and 

20 ‘‘(19) shall submit an annual report to Con21 gress detailing how the Office of National Drug 

22 Control Policy has consulted with and assisted State 

23 and local governments with respect to the formula24 tion and implementation of the National Drug Con25 trol Strategy and other relevant issues.’’. 


ccoleman on PROD1PC71 with BILLS
12 

•S 2560 IS

1 (c) REVIEW AND CERTIFICATION OF NATIONAL

2 DRUG CONTROL PROGRAM BUDGET.—Section 704(c)(3) 

3 is amended— 

4 (1) in subparagraph (C)(iii), by inserting ‘‘and 

5 the appropriate congressional committees,’’ after 

6 ‘‘House of Representatives’’; and 

7 (2) in subparagraph (D)(ii)(II)(bb), by insert8 ing ‘‘and the appropriate congressional committees,’’ 

9 after ‘‘House of Representatives’’. 

10 (d) POWERS OF DIRECTOR.—Section 704(d) is 

11 amended— 

12 (1) in paragraph (9)— 

13 (A) by inserting ‘‘notwithstanding any 

14 other provision of law,’’ after ‘‘(9)’’; and 

15 (B) by striking ‘‘Strategy; and’’ and insert16 ing ‘‘Strategy and notify the appropriate con17 gressional committees of any fund control no18 tice issued in accordance with section 

19 704(f)(5);’’; and 

20 (2) in paragraph (10), by inserting before the 

21 period the following: ‘‘and section 706 of the De22 partment of State Authorization Act for Fiscal Year 

23 2003 (22 U.S.C. 229j–1)’’. 

24 (e) FUND CONTROL NOTICES.—Section 704(f) is 

25 amended by adding at the end the following: 


ccoleman on PROD1PC71 with BILLS
13 

•S 2560 IS

1 ‘‘(4) CONGRESSIONAL NOTICE.—A copy of each 

2 fund control notice shall be transmitted to the ap3 propriate congressional committees. 

4 ‘‘(5) RESTRICTIONS.—The Director shall not 

5 issue a fund control notice to direct that all or part 

6 of an amount appropriated to the National Drug 

7 Control Program agency account be obligated, modi8 fied, or altered in any manner— 

9 ‘‘(A) contrary, in whole or in part, to a 

10 specific appropriation; or 

11 ‘‘(B) contrary, in whole or in part, to the 

12 expressed intent of Congress.’’. 

13 (f) UNITED STATES INTERDICTION COORDINATOR.— 

14 (1) IN GENERAL.—Section 704 is amended by 

15 adding at the end the following: 

16 ‘‘(i) UNITED STATES INTERDICTION COORDI17 NATOR.— 

18 ‘‘(1) IN GENERAL.—There shall be a United 

19 States Interdiction Coordinator, who shall be des20 ignated by the Director and who shall be responsible 

21 for the coordination of interdiction operations among 

22 National Drug Control Program agencies to prevent 

23 and reduce the illegal importation of drugs into the 

24 United States. 


ccoleman on PROD1PC71 with BILLS
14 

•S 2560 IS

1 ‘‘(2) RESPONSIBILITIES.—The United States 

2 Interdiction Coordinator shall be responsible to the 

3 Director for— 

4 ‘‘(A) coordinating the interdiction activities 

5 of the National Drug Control Program agencies 

6 to ensure consistency with the National Drug 

7 Control Strategy; 

8 ‘‘(B) developing a National Drug Control 

9 Interdiction plan to ensure consistency with the 

10 National Drug Control Strategy; 

11 ‘‘(C) assessing the sufficiency of assets of 

12 the National Drug Control Program agencies 

13 committed to illicit drug interdiction; and 

14 ‘‘(D) advising the Director on the efforts 

15 of each National Drug Control Program Agency 

16 to implement the National Drug Control Inter17 diction plan.’’. 

18 (2) AMENDMENT TO HOMELAND SECURITY ACT

19 OF 2002.—Section 878 of the Homeland Security Act 

20 of 2002 (6 U.S.C. 458) is amended by striking 

21 ‘‘shall—’’ through paragraph (2) and inserting 

22 ‘‘shall ensure the adequacy of resources within the 

23 Department for illicit drug interdiction.’’. 


ccoleman on PROD1PC71 with BILLS
15 

•S 2560 IS

1 SEC. 104. AMENDMENTS TO ENSURE COORDINATION WITH 

2 OTHER AGENCIES. 

3 Section 705 is amended— 

4 (1) in subsection (a)(1)(A), by striking 

5 ‘‘abuse’’; 

6 (2) by amending subsection (a)(3) to read as 

7 follows: 

8 ‘‘(3) REQUIRED REPORTS.— 

9 ‘‘(A) SECRETARIES OF THE INTERIOR AND

10 AGRICULTURE.—Not later than July 1 of each 

11 year, the Secretaries of Agriculture and the In12 terior shall jointly submit to the Director and 

13 the appropriate congressional committees an as14 sessment of the quantity of illegal drug cultiva15 tion and manufacturing in the United States on 

16 lands owned or under the jurisdiction of the 

17 Federal Government for the preceding year. 

18 ‘‘(B) SECRETARY OF HOMELAND SECU19 RITY.—Not later than July 1 of each year, the 

20 Secretary of Homeland Security shall submit to 

21 the Director and the appropriate congressional 

22 committees information for the preceding year 

23 regarding— 

24 ‘‘(i) the number and type of seizures 

25 of drugs by each component of the Depart26 ment of Homeland Security seizing drugs, 


ccoleman on PROD1PC71 with BILLS
16 

•S 2560 IS

1 as well as statistical information on the ge2 ographic areas of such seizures; and 

3 ‘‘(ii) the number of air and maritime 

4 patrol hours primarily dedicated to drug 

5 supply reduction missions undertaken by 

6 each component of the Department of 

7 Homeland Security. 

8 ‘‘(C) SECRETARY OF DEFENSE.—The Sec9 retary of Defense shall, by July 1 of each year, 

10 submit to the Director and the appropriate con11 gressional committees information for the pre12 ceding year regarding the number of air and 

13 maritime patrol hours primarily dedicated to 

14 drug supply reduction missions undertaken by 

15 each component of the Department of De16 fense.’’; and 

17 (3) in subsection (b)(2)(B), by striking ‘‘Pro18 gram’’ and inserting ‘‘Strategy’’. 

19 TITLE II—THE NATIONAL DRUG 

20 CONTROL STRATEGY 

21 SEC. 201. ANNUAL PREPARATION AND SUBMISSION OF NA22 TIONAL DRUG CONTROL STRATEGY. 

23 Section 706 is amended to read as follows: 


ccoleman on PROD1PC71 with BILLS
17 

•S 2560 IS

1 ‘‘SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 

2 AND ASSESSMENT OF NATIONAL DRUG CON3 TROL STRATEGY. 

4 ‘‘(a) TIMING, CONTENTS, AND PROCESS FOR DEVEL5 OPMENT AND SUBMISSION OF NATIONAL DRUG CONTROL

6 STRATEGY.— 

7 ‘‘(1) TIMING.—Not later than February 1 of 

8 each year, the President shall submit to Congress a 

9 National Drug Control Strategy, which shall set 

10 forth a comprehensive plan for the year to reduce 

11 drug abuse and the consequences of such drug abuse 

12 in the United States by limiting the availability of, 

13 and reducing the demand for, illegal drugs. 

14 ‘‘(2) CONTENTS.— 

15 ‘‘(A) IN GENERAL.—The National Drug 

16 Control Strategy submitted under paragraph 

17 (1) shall include— 

18 ‘‘(i) comprehensive, research-based, 

19 long-range, quantifiable goals for reducing 

20 drug abuse and the consequences of drug 

21 abuse in the United States; 

22 ‘‘(ii) annual quantifiable and measur23 able objectives and specific targets to ac24 complish long-term quantifiable goals that 

25 the Director determines may be achieved 

26 during each year beginning on the date on 


ccoleman on PROD1PC71 with BILLS
18 

•S 2560 IS

1 which the National Drug Control Strategy 

2 is submitted; 

3 ‘‘(iii) 5-year projections for program 

4 and budget priorities; 

5 ‘‘(iv) a review of international, State, 

6 local, and private sector drug control ac7 tivities to ensure that the United States 

8 pursues coordinated and effective drug 

9 control at all levels of government; 

10 ‘‘(v) an assessment of current illicit 

11 drug use (including inhalants) and avail12 ability, impact of illicit drug use, and 

13 treatment availability, which assessment 

14 shall include— 

15 ‘‘(I) estimates of drug prevalence 

16 and frequency of use as measured by 

17 national, State, and local surveys of il18 licit drug use and by other special 

19 studies of nondependent and depend20 ent illicit drug use; 

21 ‘‘(II) illicit drug use in the work22 place and the productivity lost by such 

23 use; and 

24 ‘‘(III) illicit drug use by 

25 arrestees, probationers, and parolees; 


ccoleman on PROD1PC71 with BILLS
19 

•S 2560 IS

1 ‘‘(vi) an assessment of the reduction 

2 of illicit drug availability, as measured 

3 by— 

4 ‘‘(I) the quantities of cocaine, 

5 heroin, marijuana, methamphetamine, 

6 ecstasy, and other drugs available for 

7 consumption in the United States; 

8 ‘‘(II) the amount of marijuana, 

9 cocaine, heroin, methamphetamine, ec10 stasy, and precursor chemicals and 

11 other drugs entering the United 

12 States; 

13 ‘‘(III) the number of illicit drug 

14 manufacturing laboratories seized and 

15 destroyed and the number of hectares 

16 of marijuana, poppy, and coca cul17 tivated and destroyed domestically 

18 and in other countries; 

19 ‘‘(IV) the number of metric tons 

20 of marijuana, heroin, cocaine, and 

21 methamphetamine seized and other 

22 drugs; and 

23 ‘‘(V) changes in the price and 

24 purity of heroin, methamphetamine, 

25 and cocaine, changes in the price of 


ccoleman on PROD1PC71 with BILLS
20 

•S 2560 IS

1 ecstasy, and changes in 

2 tetrahydrocannabinol level of mari3 juana and other drugs; 

4 ‘‘(vii) an assessment of the reduction 

5 of the consequences of illicit drug use and 

6 availability, which shall include— 

7 ‘‘(I) the burden illicit drug users 

8 placed on hospital emergency depart9 ments in the United States, such as 

10 the quantity of illicit drug-related 

11 services provided; 

12 ‘‘(II) the annual national health 

13 care cost of illicit drug use; and 

14 ‘‘(III) the extent of illicit drug15 related crime and criminal activity; 

16 ‘‘(viii) a determination of the status of 

17 drug treatment in the United States, by 

18 assessing— 

19 ‘‘(I) public and private treatment 

20 utilization; and 

21 ‘‘(II) the number of illicit drug 

22 users the Director estimates meet di23 agnostic criteria for treatment; 

24 ‘‘(ix) a review of the research agenda 

25 of the Counterdrug Technology Assessment 


ccoleman on PROD1PC71 with BILLS
21 

•S 2560 IS

1 Center to reduce the availability and abuse 

2 of drugs; and 

3 ‘‘(x) a summary of the efforts made to 

4 coordinate with private sector entities to 

5 conduct private research and development 

6 of medications to treat addiction by— 

7 ‘‘(I) screening chemicals for po8 tential therapeutic value; 

9 ‘‘(II) developing promising com10 pounds; 

11 ‘‘(III) conducting clinical trials; 

12 ‘‘(IV) seeking Food and Drug 

13 Administration approval for drugs to 

14 treat addiction; 

15 ‘‘(V) marketing the drug for the 

16 treatment of addiction; 

17 ‘‘(VI) urging physicians to use 

18 the drug in the treatment of addic19 tion; and 

20 ‘‘(VII) encouraging insurance 

21 companies to reimburse the cost of 

22 the drug for the treatment of addic23 tion. 

24 ‘‘(B) CLASSIFIED INFORMATION.—Any 

25 contents of the National Drug Control Strategy 


ccoleman on PROD1PC71 with BILLS
22 

•S 2560 IS

1 that involve information properly classified 

2 under criteria established by an Executive order 

3 shall be presented to Congress separately from 

4 the rest of the National Drug Control Strategy. 

5 ‘‘(3) PROCESS FOR DEVELOPMENT AND SUB6 MISSION.—In developing and effectively imple7 menting the National Drug Control Strategy, the 

8 Director— 

9 ‘‘(A) shall consult with— 

10 ‘‘(i) the heads of the National Drug 

11 Control Program agencies; 

12 ‘‘(ii) Congress; 

13 ‘‘(iii) State and local officials; 

14 ‘‘(iv) private citizens and organiza15 tions with experience and expertise in de16 mand reduction; 

17 ‘‘(v) private citizens and organizations 

18 with experience and expertise in supply re19 duction; and 

20 ‘‘(vi) appropriate representatives of 

21 foreign governments; 

22 ‘‘(B) in satisfying the requirements of sub23 paragraph (A), shall ensure, to the maximum 

24 extent possible, that State and local officials 

25 and relevant private organizations commit to 


ccoleman on PROD1PC71 with BILLS
23 

•S 2560 IS

1 support and take steps to achieve the goals and 

2 objectives of the National Drug Control Strat3 egy; 

4 ‘‘(C) with the concurrence of the Attorney 

5 General, may require the El Paso Intelligence 

6 Center to undertake specific tasks or projects to 

7 support or implement the National Drug Con8 trol Strategy; and 

9 ‘‘(D) with the concurrence of the Director 

10 of National Intelligence and the Attorney Gen11 eral, may request that the National Drug Intel12 ligence Center undertake specific tasks or 

13 projects to support or implement the National 

14 Drug Control Strategy. 

15 ‘‘(b) SUBMISSION OF REVISED STRATEGY.—The 

16 President may submit to Congress a revised National 

17 Drug Control Strategy that meets the requirements of this 

18 section— 

19 ‘‘(1) at any time, upon a determination of the 

20 President, in consultation with the Director, that the 

21 National Drug Control Strategy in effect is not suf22 ficiently effective; or 

23 ‘‘(2) if a new President or Director takes of24 fice.’’. 


ccoleman on PROD1PC71 with BILLS
24 

•S 2560 IS

1 SEC. 202. PERFORMANCE MEASUREMENTS. 

2 Section 706 is amended by adding at the end the fol3 lowing: 

4 ‘‘(c) PERFORMANCE MEASUREMENT SYSTEM.—Not 

5 later than February 1 of each year, the Director shall sub6 mit to Congress as part of the National Drug Control 

7 Strategy, a description of a national drug control perform8 ance measurement system, that— 

9 ‘‘(1) develops 2-year and 5-year performance 

10 measures and targets for each National Drug Con11 trol Strategy goal and objective established for re12 ducing drug use, availability, and the consequences 

13 of drug use; 

14 ‘‘(2) describes the sources of information and 

15 data that will be used for each performance measure 

16 incorporated into the performance measurement sys17 tem; 

18 ‘‘(3) identifies major programs and activities of 

19 the National Drug Control Program agencies that 

20 support the goals and annual objectives of the Na21 tional Drug Control Strategy; 

22 ‘‘(4) evaluates the contribution of demand re23 duction and supply reduction activities as defined in 

24 section 702 implemented by each National Drug 

25 Control Program agency in support of the National 

26 Drug Control Strategy; 


ccoleman on PROD1PC71 with BILLS
25 

•S 2560 IS

1 ‘‘(5) monitors consistency between the drug-re2 lated goals and objectives of the National Drug Con3 trol Program agencies and ensures that each agen4 cy’s goals and budgets support and are fully con5 sistent with the National Drug Control Strategy; 

6 and 

7 ‘‘(6) coordinates the development and imple8 mentation of national drug control data collection 

9 and reporting systems to support policy formulation 

10 and performance measurement, including an assess11 ment of— 

12 ‘‘(A) the quality of current drug use meas13 urement instruments and techniques to measure 

14 supply reduction and demand reduction activi15 ties; 

16 ‘‘(B) the adequacy of the coverage of exist17 ing national drug use measurement instruments 

18 and techniques to measure the casual drug use 

19 population, the addicted drug user population, 

20 and groups that are at risk for drug use; 

21 ‘‘(C) the adequacy of the coverage of exist22 ing national treatment outcome monitoring sys23 tems to measure the effectiveness of drug abuse 

24 treatment in reducing drug use and criminal 


ccoleman on PROD1PC71 with BILLS
26 

•S 2560 IS

1 behavior during and after the completion of 

2 substance abuse treatment; and 

3 ‘‘(D) the actions the Director shall take to 

4 correct any deficiencies and limitations identi5 fied pursuant to subparagraphs (A) and (B) of 

6 this subsection. 

7 ‘‘(d) MODIFICATIONS.—A description of any modi8 fications made during the preceding year to the national 

9 drug performance measurement system described in sub10 section (c) shall be included in each report submitted 

11 under subsection (b).’’. 

12 SEC. 203. ANNUAL REPORT REQUIREMENT. 

13 (a) IN GENERAL.—On or before February 1 of each 

14 year, the Director shall submit a report to Congress that 

15 describes— 

16 (1) the strategy of the national media campaign 

17 and whether specific objectives of the campaign were 

18 accomplished; 

19 (2) steps taken to ensure that the national 

20 media campaign operates in an effective and effi21 cient manner consistent with the overall strategy 

22 and focus of the campaign; 

23 (3) plans to purchase advertising time and 

24 space; 


ccoleman on PROD1PC71 with BILLS
27 

•S 2560 IS

1 (4) policies and practices implemented to ensure 

2 that Federal funds are used responsibly to purchase 

3 advertising time and space and eliminate the poten4 tial for waste, fraud, and abuse; 

5 (5) all contracts entered into with a corpora6 tion, partnership, or individual working on behalf of 

7 the national media campaign; 

8 (6) specific policies and steps implemented to 

9 ensure compliance with title IV of this Act; 

10 (7) steps taken to ensure that the national 

11 media campaign will secure, to the maximum extent 

12 possible, no cost matches of advertising time and 

13 space or in-kind contributions that are directly re14 lated to the campaign in accordance with title IV of 

15 this Act; and 

16 (8) a review and evaluation of the effectiveness 

17 of the national media campaign strategy for the past 

18 year. 

19 (b) AUDIT.—The Government Accountability Office 

20 shall, at a frequency of not less than once per year— 

21 (1) conduct and supervise an audit and inves22 tigation relating to the programs and operations of 

23 the— 

24 (A) Office; or 


ccoleman on PROD1PC71 with BILLS
28 

•S 2560 IS

1 (B) certain programs within the Office, in2 cluding— 

3 (i) the High Intensity Drug Traf4 ficking Areas Program; 

5 (ii) the Counterdrug Technology As6 sessment Center; or 

7 (iii) the National Youth Anti-drug 

8 Media Campaign; and 

9 (2) provide the Director and the appropriate 

10 congressional committees with a report containing 

11 an evaluation of and recommendations on the— 

12 (A) policies and activities of the programs 

13 and operations subject to the audit and inves14 tigation; 

15 (B) economy, efficiency, and effectiveness 

16 in the administration of the reviewed programs 

17 and operations; and 

18 (C) policy or management changes needed 

19 to prevent and detect fraud and abuse in such 

20 programs and operations. 

21 TITLE III—HIGH INTENSITY 

22 DRUG TRAFFICKING AREAS 

23 SEC. 301. HIGH INTENSITY DRUG TRAFFICKING AREAS 

24 PROGRAM. 

25 Section 707 is amended to read as follows: 


ccoleman on PROD1PC71 with BILLS
29 

•S 2560 IS

1 ‘‘SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS 

2 PROGRAM. 

3 ‘‘(a) ESTABLISHMENT.— 

4 ‘‘(1) IN GENERAL.—There is established in the 

5 Office a program to be known as the High Intensity 

6 Drug Trafficking Areas Program (in this section re7 ferred to as the ‘Program’). 

8 ‘‘(2) PURPOSE.—The purpose of the Program 

9 is to reduce drug trafficking and drug production in 

10 the United States by— 

11 ‘‘(A) facilitating cooperation among Fed12 eral, State, and local law enforcement agencies 

13 to share information and implement coordinated 

14 enforcement activities; 

15 ‘‘(B) enhancing intelligence sharing among 

16 Federal, State, and local law enforcement agen17 cies; 

18 ‘‘(C) providing reliable intelligence to law 

19 enforcement agencies needed to design effective 

20 enforcement strategies and operations; and 

21 ‘‘(D) supporting coordinated law enforce22 ment strategies which maximize use of available 

23 resources to reduce the supply of illegal drugs 

24 in designated areas and in the United States as 

25 a whole. 

26 ‘‘(b) DESIGNATION.— 


ccoleman on PROD1PC71 with BILLS
30 

•S 2560 IS

1 ‘‘(1) IN GENERAL.—The Director, in consulta2 tion with the Attorney General, the Secretary of the 

3 Treasury, the Secretary of Homeland Security, 

4 heads of the National Drug Control Program agen5 cies, and the Governor of each applicable State, may 

6 designate any specified area of the United States as 

7 a high intensity drug trafficking area. 

8 ‘‘(2) ACTIVITIES.—After making a designation 

9 under paragraph (1) and in order to provide Federal 

10 assistance to the area so designated, the Director 

11 may— 

12 ‘‘(A) obligate such sums as are appro13 priated for the Program; 

14 ‘‘(B) direct the temporary reassignment of 

15 Federal personnel to such area, subject to the 

16 approval of the head of the department or agen17 cy that employs such personnel; 

18 ‘‘(C) take any other action authorized 

19 under section 704 to provide increased Federal 

20 assistance to those areas; and 

21 ‘‘(D) coordinate activities under this sec22 tion (specifically administrative, recordkeeping, 

23 and funds management activities) with State 

24 and local officials. 


ccoleman on PROD1PC71 with BILLS
31 

•S 2560 IS

1 ‘‘(c) PETITIONS FOR DESIGNATION.—The Director 

2 shall establish regulations under which a coalition of inter3 ested law enforcement agencies from an area may petition 

4 for designation as a high intensity drug trafficking area. 

5 Such regulations shall provide for a regular review by the 

6 Director of the petition, including a recommendation re7 garding the merit of the petition to the Director by a panel 

8 of qualified, independent experts. 

9 ‘‘(d) FACTORS FOR CONSIDERATION.—In considering 

10 whether to designate an area under this section as a high 

11 intensity drug trafficking area, the Director shall consider, 

12 in addition to such other criteria as the Director considers 

13 to be appropriate, the extent to which— 

14 ‘‘(1) the area is a significant center of illegal 

15 drug production, manufacturing, importation, or dis16 tribution; 

17 ‘‘(2) State and local law enforcement agencies 

18 have committed resources to respond to the drug 

19 trafficking problem in the area, thereby indicating a 

20 determination to respond aggressively to the prob21 lem; 

22 ‘‘(3) drug-related activities in the area are hav23 ing a significant harmful impact in the area, and in 

24 other areas of the country; and 


ccoleman on PROD1PC71 with BILLS
32 

•S 2560 IS

1 ‘‘(4) a significant increase in allocation of Fed2 eral resources is necessary to respond adequately to 

3 drug-related activities in the area. 

4 ‘‘(e) ORGANIZATION OF HIGH INTENSITY DRUG

5 TRAFFICKING AREAS.— 

6 ‘‘(1) EXECUTIVE BOARD AND OFFICERS.—To 

7 be eligible for funds appropriated under this section, 

8 each high intensity drug trafficking area shall be 

9 governed by an Executive Board. The Executive 

10 Board shall designate a chairman, vice chairman, 

11 and any other officers to the Executive Board that 

12 it determines are necessary. 

13 ‘‘(2) RESPONSIBILITIES.—The Executive Board 

14 of a high intensity drug trafficking area shall be re15 sponsible for— 

16 ‘‘(A) providing direction and oversight in 

17 establishing and achieving the goals of the high 

18 intensity drug trafficking area; 

19 ‘‘(B) managing the funds of the high in20 tensity drug trafficking area; 

21 ‘‘(C) reviewing and approving all funding 

22 proposals consistent with the overall objective of 

23 the high intensity drug trafficking area; and 


ccoleman on PROD1PC71 with BILLS
33 

•S 2560 IS

1 ‘‘(D) reviewing and approving all reports 

2 to the Director on the activities of the high in3 tensity drug trafficking area. 

4 ‘‘(3) BOARD REPRESENTATION.—None of the 

5 funds appropriated under this section may be ex6 pended for any high intensity drug trafficking area, 

7 or for a partnership or region of a high intensity 

8 drug trafficking area, if the Executive Board for 

9 such area, region, or partnership, does not apportion 

10 an equal number of votes between representatives of 

11 participating Federal agencies and representatives of 

12 participating State and local agencies. Where it is 

13 impractical for an equal number of representatives 

14 of Federal agencies and State and local agencies to 

15 attend a meeting of an Executive Board in person, 

16 the Executive Board may use a system of proxy 

17 votes or weighted votes to achieve the voting balance 

18 required by this paragraph. 

19 ‘‘(4) NO AGENCY RELATIONSHIP.—The eligi20 bility requirements of this section are intended to 

21 ensure the responsible use of Federal funds. Nothing 

22 in this section is intended to create an agency rela23 tionship between individual high intensity drug traf24 ficking areas and the Federal Government. 


ccoleman on PROD1PC71 with BILLS
34 

•S 2560 IS

1 ‘‘(f) USE OF FUNDS.—The Director shall ensure that 

2 no Federal funds appropriated for the Program are ex3 pended for the establishment or expansion of drug treat4 ment programs, and shall ensure that not more than 5 

5 percent of the Federal funds appropriated for the Pro6 gram are expended for the establishment of drug preven7 tion programs. 

8 ‘‘(g) COUNTERTERRORISM ACTIVITIES.— 

9 ‘‘(1) ASSISTANCE AUTHORIZED.—The Director 

10 may authorize use of resources available for the Pro11 gram to assist Federal, State, and local law enforce12 ment agencies in investigations and activities related 

13 to terrorism and prevention of terrorism, especially 

14 but not exclusively with respect to such investiga15 tions and activities that are also related to drug 

16 trafficking. 

17 ‘‘(2) LIMITATION.—The Director shall ensure— 

18 ‘‘(A) that assistance provided under para19 graph (1) remains incidental to the purpose of 

20 the Program to reduce drug availability and 

21 carry out drug-related law enforcement activi22 ties; and 

23 ‘‘(B) that significant resources of the Pro24 gram are not redirected to activities exclusively 

25 related to terrorism, except on a temporary 


ccoleman on PROD1PC71 with BILLS
35 

•S 2560 IS

1 basis under extraordinary circumstances, as de2 termined by the Director. 

3 ‘‘(h) ROLE OF DRUG ENFORCEMENT ADMINISTRA4 TION.—The Director, in consultation with the Attorney 

5 General, shall ensure that a representative of the Drug 

6 Enforcement Administration is included in the Intelligence 

7 Support Center for each high intensity drug trafficking 

8 area. 

9 ‘‘(i) ANNUAL HIDTA PROGRAM BUDGET SUBMIS10 SIONS.—As part of the documentation that supports the 

11 President’s annual budget request for the Office, the Di12 rector shall submit to Congress a budget justification that 

13 includes— 

14 ‘‘(1) the amount requested for each high inten15 sity drug trafficking area, with supporting narrative 

16 descriptions and rationale for each request; and 

17 ‘‘(2) a detailed justification for each funding re18 quest that explains— 

19 ‘‘(A) the reasons for the requested funding 

20 level; how such funding level was determined 

21 based on a current assessment of the drug traf22 ficking threat in each high intensity drug traf23 ficking area; 


ccoleman on PROD1PC71 with BILLS
36 

•S 2560 IS

1 ‘‘(B) how such funding will ensure that the 

2 goals and objectives of each such area will be 

3 achieved; and 

4 ‘‘(C) how such funding supports the Na5 tional Drug Control Strategy. 

6 ‘‘(j) EMERGING THREAT RESPONSE FUND.— 

7 ‘‘(1) IN GENERAL.—Subject to the availability 

8 of appropriations, the Director may expend up to 10 

9 percent of the amounts appropriated under this sec10 tion on a discretionary basis, to respond to any 

11 emerging drug trafficking threat in an existing high 

12 intensity drug trafficking area, or to establish a new 

13 high intensity drug trafficking area or expand an ex14 isting high intensity drug trafficking area, in accord15 ance with the criteria established under paragraph 

16 (2). 

17 ‘‘(2) CONSIDERATION OF IMPACT.—In allo18 cating funds under this subsection, the Director 

19 shall consider— 

20 ‘‘(A) the impact of activities funded on re21 ducing overall drug traffic in the United States, 

22 or minimizing the probability that an emerging 

23 drug trafficking threat will spread to other 

24 areas of the United States; and 


ccoleman on PROD1PC71 with BILLS
37 

•S 2560 IS

1 ‘‘(B) such other criteria as the Director 

2 considers appropriate. 

3 ‘‘(k) EVALUATION.— 

4 ‘‘(1) INITIAL REPORT.—Not later than 90 days 

5 after the date of the enactment of this section, the 

6 Director shall, after consulting with the Executive 

7 Boards of each designated high intensity drug traf8 ficking area, submit a report to Congress that de9 scribes, for each designated high intensity drug traf10 ficking area— 

11 ‘‘(A) the specific purposes for the high in12 tensity drug trafficking area; 

13 ‘‘(B) the specific long-term and short-term 

14 goals and objectives for the high intensity drug 

15 trafficking area; 

16 ‘‘(C) the measurements that will be used to 

17 evaluate the performance of the high intensity 

18 drug trafficking area in achieving the long-term 

19 and short-term goals; and 

20 ‘‘(D) the reporting requirements needed to 

21 evaluate the performance of the high intensity 

22 drug trafficking area in achieving the long-term 

23 and short-term goals. 

24 ‘‘(2) EVALUATION OF HIDTA PROGRAM AS PART

25 OF NATIONAL DRUG CONTROL STRATEGY.—For each 


ccoleman on PROD1PC71 with BILLS
38 

•S 2560 IS

1 designated high intensity drug trafficking area, the 

2 Director shall submit, as part of the annual National 

3 Drug Control Strategy report, a report that— 

4 ‘‘(A) describes— 

5 ‘‘(i) the specific purposes for the high 

6 intensity drug trafficking area; and 

7 ‘‘(ii) the specific long-term and short8 term goals and objectives for the high in9 tensity drug trafficking area; and 

10 ‘‘(B) includes an evaluation of the per11 formance of the high intensity drug trafficking 

12 area in accomplishing the specific long-term 

13 and short-term goals and objectives identified 

14 under paragraph (1)(B). 

15 ‘‘(l) ASSESSMENT OF DRUG ENFORCEMENT TASK

16 FORCES IN HIGH INTENSITY DRUG TRAFFICKING

17 AREAS.—Not later than 180 days after the date of enact18 ment of this subsection, and as part of each subsequent 

19 annual National Drug Control Strategy report, the Direc20 tor shall submit to Congress a report— 

21 ‘‘(1) assessing the number and operation of all 

22 federally funded drug enforcement task forces within 

23 each high intensity drug trafficking area; and 

24 ‘‘(2) describing— 


ccoleman on PROD1PC71 with BILLS
39 

•S 2560 IS

1 ‘‘(A) each Federal, State, and local drug 

2 enforcement task force operating in the high in3 tensity drug trafficking area; 

4 ‘‘(B) how such task forces coordinate with 

5 each other, with any high intensity drug traf6 ficking area task force, and with investigations 

7 receiving funds from the Organized Crime and 

8 Drug Enforcement Task Force; 

9 ‘‘(C) what steps, if any, each such task 

10 force takes to share information regarding drug 

11 trafficking and drug production with other fed12 erally funded drug enforcement task forces in 

13 the high intensity drug trafficking area; 

14 ‘‘(D) the role of the high intensity drug 

15 trafficking area in coordinating the sharing of 

16 such information among task forces; 

17 ‘‘(E) the nature and extent of cooperation 

18 by each Federal, State, and local participant in 

19 ensuring that such information is shared among 

20 law enforcement agencies and with the high in21 tensity drug trafficking area; 

22 ‘‘(F) the nature and extent to which infor23 mation sharing and enforcement activities are 

24 coordinated with joint terrorism task forces in 

25 the high intensity drug trafficking area; and 


ccoleman on PROD1PC71 with BILLS
40 

•S 2560 IS

1 ‘‘(G) any recommendations for measures 

2 needed to ensure that task force resources are 

3 utilized efficiently and effectively to reduce the 

4 availability of illegal drugs in the high intensity 

5 drug trafficking areas. 

6 ‘‘(m) ASSESSMENT OF INTELLIGENCE SHARING IN

7 HIGH INTENSITY DRUG TRAFFICKING AREAS PRO8 GRAM.—Not later than 180 days after the date of the en9 actment of this section, and as part of each subsequent 

10 annual National Drug Control Strategy report, the Direc11 tor, in consultation with the Director of National Intel12 ligence, shall submit to Congress a report— 

13 ‘‘(1) evaluating existing and planned intel14 ligence systems supported by each high intensity 

15 drug trafficking area, or utilized by task forces re16 ceiving any funding under the Program, including 

17 the extent to which such systems ensure access and 

18 availability of intelligence to Federal, State, and 

19 local law enforcement agencies within the high inten20 sity drug trafficking area and outside of it; 

21 ‘‘(2) the extent to which Federal, State, and 

22 local law enforcement agencies participating in each 

23 high intensity drug trafficking area are sharing in24 telligence information to assess current drug trafVerDate Aug 31 2005 02:23 Apr 08, 2006 Jkt 049196 PO 00000 Frm 00040 Fmt 6652 Sfmt 6201 E:\BILLS\S2560.IS S2560

ccoleman on PROD1PC71 with BILLS
41 

•S 2560 IS

1 ficking threats and design appropriate enforcement 

2 strategies; and 

3 ‘‘(3) the measures needed to improve effective 

4 sharing of information and intelligence regarding 

5 drug trafficking and drug production among Fed6 eral, State, and local law enforcement participating 

7 in a high intensity drug trafficking area, and be8 tween such agencies and similar agencies outside the 

9 high intensity drug trafficking area. 

10 ‘‘(n) COORDINATION OF INTELLIGENCE SHARING

11 WITH ORGANIZED CRIME DRUG ENFORCEMENT TASK

12 FORCE PROGRAM.—The Director, in consultation with the 

13 Attorney General, shall ensure that any drug enforcement 

14 intelligence obtained by the Intelligence Support Center 

15 for each high intensity drug trafficking area is shared, on 

16 a timely basis, with the drug intelligence fusion center op17 erated by the Organized Crime Drug Enforcement Task 

18 Force of the Department of Justice. 

19 ‘‘(o) USE OF FUNDS TO COMBAT METHAMPHET20 AMINE TRAFFICKING.— 

21 ‘‘(1) IN GENERAL.— 

22 ‘‘(A) REQUIREMENT.—The Director shall 

23 ensure that, of the amounts appropriated for a 

24 fiscal year for the Program, at least 

25 $15,000,000 is allocated to combat the trafVerDate Aug 31 2005 02:23 Apr 08, 2006 Jkt 049196 PO 00000 Frm 00041 Fmt 6652 Sfmt 6201 E:\BILLS\S2560.IS S2560

ccoleman on PROD1PC71 with BILLS
42 

•S 2560 IS

1 ficking of methamphetamine in areas des2 ignated by the Director as high intensity drug 

3 trafficking areas. 

4 ‘‘(B) ACTIVITIES.—In meeting the require5 ment in subparagraph (A), the Director shall 

6 transfer funds to appropriate Federal, State, 

7 and local governmental agencies for employing 

8 additional Federal law enforcement personnel, 

9 or facilitating the employment of additional 

10 State and local law enforcement personnel, in11 cluding agents, investigators, prosecutors, lab12 oratory technicians, chemists, investigative as13 sistants, and drug prevention specialists. 

14 ‘‘(2) APPORTIONMENT OF FUNDS.— 

15 ‘‘(A) FACTORS IN APPORTIONMENT.—The 

16 Director shall apportion amounts allocated 

17 under paragraph (1) among areas designated by 

18 the Director as high intensity drug trafficking 

19 areas based on the following factors: 

20 ‘‘(i) The number of methamphetamine 

21 manufacturing facilities discovered by Fed22 eral, State, or local law enforcement offi23 cials in the area during the previous fiscal 

24 year. 


ccoleman on PROD1PC71 with BILLS
43 

•S 2560 IS

1 ‘‘(ii) The number of methamphet2 amine prosecutions in Federal, State, or 

3 local courts in the area during the previous 

4 fiscal year. 

5 ‘‘(iii) The number of methamphet6 amine arrests by Federal, State, or local 

7 law enforcement officials in the area dur8 ing the previous fiscal year. 

9 ‘‘(iv) The amounts of methamphet10 amine or listed chemicals (as that term is 

11 defined in section 102(33) of the Con12 trolled Substances Act (21 U.S.C. 

13 802(33)) seized by Federal, State, or local 

14 law enforcement officials in the area dur15 ing the previous fiscal year. 

16 ‘‘(v) Intelligence and predictive data 

17 from the Drug Enforcement Administra18 tion showing patterns and trends in abuse, 

19 trafficking, and transportation in meth20 amphetamine and listed chemicals (as that 

21 term is so defined). 

22 ‘‘(B) CERTIFICATION.—Before the Direc23 tor apportions any funds under this paragraph 

24 to a high intensity drug trafficking area, the 

25 Director shall certify that the law enforcement 


ccoleman on PROD1PC71 with BILLS
44 

•S 2560 IS

1 entities responsible for clandestine methamphet2 amine laboratory seizures in that area are pro3 viding laboratory seizure data to the national 

4 clandestine laboratory database at the El Paso 

5 Intelligence Center. 

6 ‘‘(p) AUTHORIZATION OF APPROPRIATIONS.—There 

7 is authorized to be appropriated to the Office of National 

8 Drug Control Policy to carry out this section— 

9 ‘‘(1) $280,000,000 for fiscal year 2007; 

10 ‘‘(2) $290,000,000 for each of fiscal years 2008 

11 and 2009; and 

12 ‘‘(3) $300,000,000 for each of fiscal years 2010 

13 and 2011.’’. 

14 SEC. 302. FUNDING FOR CERTAIN HIGH INTENSITY DRUG 

15 TRAFFICKING AREAS. 

16 (a) SHORT TITLE.—This section may be cited as the 

17 ‘‘Dawson Family Community Protection Act’’. 

18 (b) FINDINGS.—Congress finds the following: 

19 (1) In the early morning hours of October 16, 

20 2002, the home of Carnell and Angela Dawson was 

21 firebombed in apparent retaliation for Mrs. 

22 Dawson’s notification to police about persistent drug 

23 distribution activity in their East Baltimore City 

24 neighborhood. 


ccoleman on PROD1PC71 with BILLS
45 

•S 2560 IS

1 (2) The arson claimed the lives of Mr. and Mrs. 

2 Dawson and their 5 young children, aged 9 to 14. 

3 (3) The horrific murder of the Dawson family 

4 is a stark example of domestic narco-terrorism. 

5 (4) In all phases of counternarcotics law en6 forcement—from prevention to investigation to pros7 ecution to reentry—the voluntary cooperation of or8 dinary citizens is a critical component. 

9 (5) Voluntary cooperation is difficult for law en10 forcement officials to obtain when citizens feel that 

11 cooperation carries the risk of violent retaliation by 

12 illegal drug trafficking organizations and their affili13 ates. 

14 (6) Public confidence that law enforcement is 

15 doing all it can to make communities safe is a pre16 requisite for voluntary cooperation among people 

17 who may be subject to intimidation or reprisal (or 

18 both). 

19 (7) Witness protection programs are insufficient 

20 on their own to provide security because many indi21 viduals and families who strive every day to make 

22 distressed neighborhoods livable for their children, 

23 other relatives, and neighbors will resist or refuse of24 fers of relocation by local, State, and Federal pros25 ecutorial agencies and because, moreover, the continVerDate Aug 31 2005 02:23 Apr 08, 2006 Jkt 049196 PO 00000 Frm 00045 Fmt 6652 Sfmt 6201 E:\BILLS\S2560.IS S2560

ccoleman on PROD1PC71 with BILLS
46 

•S 2560 IS

1 ued presence of strong individuals and families is 

2 critical to preserving and strengthening the social 

3 fabric in such communities. 

4 (8) Where (as in certain sections of Baltimore 

5 City) interstate trafficking of illegal drugs has severe 

6 ancillary local consequences within areas designated 

7 as high intensity drug trafficking areas, it is impor8 tant that supplementary High Intensity Drug Traf9 ficking Areas Program funds be committed to sup10 port initiatives aimed at making the affected com11 munities safe for the residents of those communities 

12 and encouraging their cooperation with local, State, 

13 and Federal law enforcement efforts to combat ille14 gal drug trafficking. 

15 (c) FUNDING FOR CERTAIN HIGH INTENSITY DRUG

16 TRAFFICKING AREAS.—Section 707, as amended by sec17 tion 301, is amended by adding at the end the following: 

18 ‘‘(q) SPECIFIC PURPOSES.— 

19 ‘‘(1) IN GENERAL.—The Director shall ensure 

20 that, of the amounts appropriated for a fiscal year 

21 for the Program, at least $7,000,000 is used in high 

22 intensity drug trafficking areas with severe neigh23 borhood safety and illegal drug distribution prob24 lems. 


ccoleman on PROD1PC71 with BILLS
47 

•S 2560 IS

1 ‘‘(2) REQUIRED USES.—The funds used under 

2 paragraph (1) shall be used— 

3 ‘‘(A) to ensure the safety of neighborhoods 

4 and the protection of communities, including 

5 the prevention of the intimidation of potential 

6 witnesses of illegal drug distribution and related 

7 activities; and 

8 ‘‘(B) to combat illegal drug trafficking 

9 through such methods as the Director considers 

10 appropriate, such as establishing or operating 

11 (or both) a toll-free telephone hotline for use by 

12 the public to provide information about illegal 

13 drug-related activities.’’. 

14 SEC. 303. ASSESSMENT. 

15 The Director shall assess the ability of the HIDTA 

16 Program to respond to the so-called ‘‘balloon effect’’, 

17 whereby urban drug traffickers facing intensive law en18 forcement efforts expand and spread their trafficking and 

19 distribution into rural, suburban, and smaller urban areas 

20 by conducting a demonstration project examining the abil21 ity of the New York/New Jersey HIDTA, with its new sin22 gle colocated Organized Crime and Drug Enforcement 

23 Task Force/High Intensity Drug Trafficking Area Strike 

24 Force and HIDTA Regional Intelligence Center, to ad25 dress the movement of drug traffickers into the more 


ccoleman on PROD1PC71 with BILLS
48 

•S 2560 IS

1 rural, suburban, and smaller areas encompassed by the 

2 counties of Albany, Onondaga, Monroe, and Erie in New 

3 York State and by annexing these counties into the exist4 ing New York/New Jersey HIDTA. 

5 TITLE IV—TECHNOLOGY 

6 SEC. 401. COUNTERDRUG TECHNOLOGY ASSESSMENT CEN7 TER. 

8 (a) CHIEF SCIENTIST.—Section 708(b) is amended 

9 to read as follows: 

10 ‘‘(b) CHIEF SCIENTIST.—There shall be at the head 

11 of the Center the Chief Scientist, who shall be appointed 

12 by the Director from among individuals qualified and dis13 tinguished in the area of science, medicine, engineering, 

14 or technology.’’. 

15 (b) RESPONSIBILITIES.— 

16 (1) RESEARCH AND DEVELOPMENT.—Section 

17 708 is amended by— 

18 (A) redesignating subsection (d) as sub19 section (e); and 

20 (B) striking subsection (c) and inserting 

21 the following: 

22 ‘‘(c) RESEARCH AND DEVELOPMENT RESPONSIBIL23 ITIES.—The Chief Scientist shall be responsible to the Di24 rector for— 


ccoleman on PROD1PC71 with BILLS
49 

•S 2560 IS

1 ‘‘(1) identifying and defining the short-, me2 dium-, and long-term scientific and technological 

3 needs of Federal, State, and local drug supply re4 duction agencies, including— 

5 ‘‘(A) advanced surveillance, tracking, and 

6 radar imaging; 

7 ‘‘(B) electronic support measures; 

8 ‘‘(C) communications; 

9 ‘‘(D) data fusion, advanced computer sys10 tems, and artificial intelligence; and 

11 ‘‘(E) chemical, biological, radiological (in12 cluding neutron and electron), and other means 

13 of detection; 

14 ‘‘(2) identifying demand reduction basic and 

15 applied research needs and initiatives, in consulta16 tion with affected National Drug Control Program 

17 agencies, including— 

18 ‘‘(A) improving treatment through 

19 neuroscientific advances; 

20 ‘‘(B) improving the transfer of biomedical 

21 research to the clinical setting; and 

22 ‘‘(C) in consultation with the National In23 stitute of Drug Abuse, and through interagency 

24 agreements or grants, examining addiction and 

25 rehabilitation research and the application of 


ccoleman on PROD1PC71 with BILLS
50 

•S 2560 IS

1 technology to expanding the effectiveness and 

2 availability of drug treatment; 

3 ‘‘(3) making a priority ranking of such needs 

4 identified in paragraphs (1) and (2) according to fis5 cal and technological feasibility, as part of a Na6 tional Counterdrug Research and Development Pro7 gram; 

8 ‘‘(4) overseeing and coordinating counterdrug 

9 technology initiatives with related activities of other 

10 Federal civilian and military departments; 

11 ‘‘(5) providing support to the development and 

12 implementation of the national drug control per13 formance measurement system established under 

14 subsection (c) of section 706; and 

15 ‘‘(6) transferring funds made available to a Na16 tional Drug Control Program Agency for 

17 counterdrug technology research and development to 

18 another account within such agency or to another 

19 National Drug Control Program Agency for 

20 counterdrug technology research and development, 

21 pursuant to the authority of the Director under sec22 tion 704. 

23 ‘‘(d) LIMITATION ON AUTHORITY.—The authority 

24 granted to the Director under this section shall not extend 


ccoleman on PROD1PC71 with BILLS
51 

•S 2560 IS

1 to the awarding of contracts, management of individual 

2 projects, or other operational activities.’’. 

3 (2) ASSISTANCE AND SUPPORT.—Subsection (e) 

4 of section 708, as redesignated by this section, is 

5 amended to read as follows: 

6 ‘‘(e) ASSISTANCE AND SUPPORT TO THE OFFICE OF

7 NATIONAL DRUG CONTROL POLICY.—The Secretary of 

8 Defense, the Secretary of Homeland Security, and the 

9 Secretary of Health and Human Services shall, to the 

10 maximum extent practicable, render assistance and sup11 port to the Office and to the Director in the conduct of 

12 counterdrug technology assessment.’’. 

13 (3) TECHNOLOGY TRANSFER PROGRAM.—Sec14 tion 708 is amended by adding at the end the fol15 lowing: 

16 ‘‘(f) TECHNOLOGY TRANSFER PROGRAM.— 

17 ‘‘(1) PROGRAM.—The Chief Scientist, with the 

18 advice and counsel of experts from State and local 

19 law enforcement agencies, shall be responsible to the 

20 Director for coordination and implementation of a 

21 counterdrug technology transfer program. 

22 ‘‘(2) PURPOSE.—The purpose of the Tech23 nology Transfer Program shall be for the 

24 Counterdrug Technology Assessment Center to 


ccoleman on PROD1PC71 with BILLS
52 

•S 2560 IS

1 transfer technology and associated training directly 

2 to State and local law enforcement agencies. 

3 ‘‘(3) PRIORITY OF RECEIPTS.—Transfers shall 

4 be made in priority order based on— 

5 ‘‘(A) the need of potential recipients for 

6 such technology; 

7 ‘‘(B) the effectiveness of the technology to 

8 enhance current counterdrug activities of poten9 tial recipients; and 

10 ‘‘(C) the ability and willingness of potential 

11 recipients to evaluate transferred technology. 

12 ‘‘(4) AGREEMENT AUTHORITY.—The Director 

13 may enter into an agreement with the Secretary of 

14 Homeland Security to transfer technology with both 

15 counterdrug and homeland security applications to 

16 State and local law enforcement agencies on a reim17 bursable basis. 

18 ‘‘(5) REPORT.—On or before July 1 of each 

19 year, the Director shall submit a report to the ap20 propriate congressional committees which addresses 

21 the following: 

22 ‘‘(A) The number of requests received dur23 ing the previous 12 months. 

24 ‘‘(B) The number of requests fulfilled dur25 ing the previous 12 months. 


ccoleman on PROD1PC71 with BILLS
53 

•S 2560 IS

1 ‘‘(C) A summary of the criteria used in 

2 making the determination on what requests 

3 were funded and what requests were not fund4 ed. 

5 ‘‘(D) A general assessment of the future 

6 needs of the program, based on expected 

7 changes in threats, expected technologies, and 

8 likely need from potential recipients. 

9 ‘‘(E) An assessment of the effectiveness of 

10 the technologies transferred, based in part on 

11 the evaluations provided by the recipients, with 

12 a recommendation whether the technology 

13 should continue to be offered through the pro14 gram.’’. 

15 TITLE V—REAUTHORIZATION 

16 AND IMPROVEMENT OF THE 

17 NATIONAL ANTI-DRUG MEDIA 

18 CAMPAIGN 

19 SEC. 501. SHORT TITLE. 

20 This title may be cited as the ‘‘National Youth Anti21 Drug Media Campaign Reauthorization Act of 2006’’. 

22 SEC. 502. PURPOSES OF THE NATIONAL YOUTH ANTI-DRUG 

23 MEDIA CAMPAIGN. 

24 The Drug-Free Media Campaign Act of 1998 (21 

25 U.S.C. 1801 et seq.) is amended— 


ccoleman on PROD1PC71 with BILLS
54 

•S 2560 IS

1 (1) in section 101, by striking ‘‘Drug-Free 

2 Media Campaign Act of 1998’’ and inserting ‘‘Na3 tional Youth Anti-Drug Media Campaign Act’’; and 

4 (2) in section 102— 

5 (A) in subsection (a), by striking ‘‘national 

6 media campaign’’ and all that follows through 

7 the period and inserting the following: ‘‘national 

8 youth anti-drug media campaign (referred to in 

9 this subtitle as the ‘national media campaign’) 

10 in accordance with this subtitle for the purposes 

11 of— 

12 ‘‘(1) preventing drug abuse among young peo13 ple in the United States; 

14 ‘‘(2) increasing awareness of adults of the im15 pact of drug abuse on young people; and 

16 ‘‘(3) encouraging parents and other interested 

17 adults to discuss with young people the dangers of 

18 illegal drug use.’’; and 

19 (B) in subsection (b), by striking ‘‘105’’ 

20 and inserting ‘‘104’’. 


ccoleman on PROD1PC71 with BILLS
55 

•S 2560 IS

1 SEC. 503. ROLES AND RESPONSIBILITIES OF THE DIREC2 TOR, THE PARTNERSHIP FOR A DRUG-FREE 

3 AMERICA, AND A MEDIA BUYING CON4 TRACTOR. 

5 The Drug-Free Media Campaign Act of 1998 (21 

6 U.S.C. 1801 et seq.) is amended— 

7 (1) by adding at the end the following: 

8 ‘‘(c) DIVISION OF RESPONSIBILITIES AND FUNC9 TIONS UNDER THE PROGRAM.— 

10 ‘‘(1) IN GENERAL.—The Director, in consulta11 tion with the Partnership for a Drug-Free America, 

12 shall determine the overall purposes and strategy of 

13 the national media campaign. 

14 ‘‘(2) RESPONSIBILITIES.— 

15 ‘‘(A) DIRECTOR.—The Director shall be 

16 responsible for implementing a focused national 

17 media campaign to meet the purposes set forth 

18 in section 102(a), and shall approve— 

19 ‘‘(i) the strategy of the national media 

20 campaign; 

21 ‘‘(ii) all advertising and promotional 

22 material used in the national media cam23 paign; and 

24 ‘‘(iii) the plan for the purchase of ad25 vertising time and space for the national 

26 media campaign. 


ccoleman on PROD1PC71 with BILLS
56 

•S 2560 IS

1 ‘‘(B) THE PARTNERSHIP FOR A DRUG2 FREE AMERICA.—The Director shall request 

3 that the Partnership for a Drug-Free Amer4 ica— 

5 ‘‘(i) develop and recommend strategies 

6 to achieve the goals of the national media 

7 campaign, including addressing national 

8 and local drug threats in specific regions 

9 or States, such as methamphetamine and 

10 ecstasy; 

11 ‘‘(ii) create all advertising to be used 

12 in the national media campaign, except ad13 vertisements that are— 

14 ‘‘(I) provided by other nonprofit 

15 entities pursuant to section 103(c); 

16 ‘‘(II) intended to reach a minor17 ity, ethnic, or other special audience 

18 that cannot be obtained at no cost 

19 (not including production costs and 

20 talent reuse payments), provided that 

21 any such advertising material is re22 viewed by the Partnership for a Drug23 Free America; or 

24 ‘‘(III) any other advertisements 

25 that the Partnership for a Drug-Free 


ccoleman on PROD1PC71 with BILLS
57 

•S 2560 IS

1 America determines it is unable to 

2 provide. 

3 ‘‘(C) MEDIA BUYING CONTRACTOR.—The 

4 Director shall enter into a contract with a 

5 media buying contractor to plan and purchase 

6 advertising time and space for the national 

7 media campaign. The media buying contractor 

8 shall not provide any service or material, or 

9 conduct any function or activity which can be 

10 provided by the Partnership for a Drug-Free 

11 America, as defined in section 403(2)(B)’’; and 

12 (2) in section 103— 

13 (A) in subparagraph (A), by inserting ‘‘, 

14 including the strategic planning for, and ac15 counting of, such purchases’’ after ‘‘space’’; 

16 (B) in subparagraph (C), by striking ‘‘out17 of-pocket’’; and 

18 (C) in subparagraph (F), by striking ‘‘the 

19 Office of National Drug Control Policy’’ and in20 serting ‘‘either the Office of National Drug 

21 Control Policy or the designee of the Office’’. 


ccoleman on PROD1PC71 with BILLS
58 

•S 2560 IS

1 SEC. 504. RESPONSIBLE USE OF FEDERAL FUNDS FOR THE 

2 NATIONAL YOUTH ANTI-DRUG MEDIA CAM3 PAIGN. 

4 The Drug-Free Media Campaign Act of 1998 (21 

5 U.S.C. 1801 et seq.) is amended— 

6 (1) in section 103, by striking paragraph (2) 

7 and inserting the following: 

8 ‘‘(2) ADVERTISING.— 

9 ‘‘(A) IN GENERAL.—Except as provided in 

10 subparagraph (B), in carrying out this subtitle, 

11 the Director shall ensure that sufficient funds 

12 are allocated to meet the stated goals of the na13 tional media campaign. 

14 ‘‘(B) EXCEPTION.—No funds shall be used 

15 for the creative development of advertisements 

16 (not including out-of-pocket production costs 

17 and talent reuse payments) except when— 

18 ‘‘(i) the advertisements are intended 

19 to reach a minority, ethnic, or other special 

20 audience that cannot be obtained at no 

21 cost (not including production costs and 

22 talent reuse payments); or 

23 ‘‘(ii) the Partnership for a Drug-Free 

24 America, determines that it is unable to 

25 provide such advertisements.’’; 


ccoleman on PROD1PC71 with BILLS
59 

•S 2560 IS

1 (2) in subsection (b), by striking ‘‘105’’ and in2 serting ‘‘104’’; 

3 (3) by striking subsection (c) and inserting the 

4 following: 

5 ‘‘(c) MATCHING REQUIREMENT.— 

6 ‘‘(1) NO COST MATCH.— 

7 ‘‘(A) IN GENERAL.—Except as provided in 

8 subparagraph (B), amounts made available for 

9 the national media campaign under section 106 

10 shall be used to require a no cost match of 

11 equivalent value of advertising broadcast time, 

12 print space, or in-kind contributions to the na13 tional media campaign. 

14 ‘‘(B) EXCEPTION.—The Director shall en15 sure that all no cost matches of advertising ma16 terial, time, space, or in-kind contributions pro17 vided pursuant to subparagraph (A) directly re18 late to substance abuse prevention and specifi19 cally promote 1 or more of the specific purposes 

20 set forth in section 102(a). This may include 

21 antismoking messages that are produced by 

22 nonprofit organizations and are targeted toward 

23 minors. 

24 ‘‘(2) SPONSORSHIP IDENTIFICATION.—Any ad25 vertising material donated to the national media 


ccoleman on PROD1PC71 with BILLS
60 

•S 2560 IS

1 campaign at no cost shall not be subject to the spon2 sorship identification provisions in section 317 of the 

3 Communications Act of 1934 (47 U.S.C. 317).’’; 

4 (4) by adding at the end the following: 

5 ‘‘(d) RESPONSIBLE USE OF FEDERAL FUNDS.— 

6 ‘‘(1) IN GENERAL.—The Director shall ensure 

7 that— 

8 ‘‘(A) for each fiscal year, not less than 77 

9 percent of the amounts appropriated under this 

10 subtitle shall be used for the activities allowed 

11 under section 103(a)(1)(A); 

12 ‘‘(B) no Federal funds provided under this 

13 subtitle are used to pay any entity for any ac14 tivity or service that duplicates, in whole or in 

15 part, any material, function, activity, or service 

16 provided by the Partnership for a Drug-Free 

17 America, as defined in section 403(2)(B); and 

18 ‘‘(C) no more than $5,000,000 is used in 

19 each fiscal year to develop advertising material 

20 pursuant to subsection (a)(2)(B)(ii).’’. 

21 SEC. 505. AUTHORIZATION FOR NATIONAL YOUTH ANTI22 DRUG MEDIA CAMPAIGN. 

23 The Drug-Free Media Campaign Act of 1998 (21 

24 U.S.C. 1801 et seq.) is amended by striking sections 104 

25 and 105 and inserting the following: 


ccoleman on PROD1PC71 with BILLS
61 

•S 2560 IS

1 ‘‘SEC. 104. AUTHORIZATION OF APPROPRIATIONS. 

2 ‘‘There is authorized to be appropriated to the Office 

3 of National Drug Control Policy to carry out this subtitle, 

4 $195,000,000 for each of the fiscal years 2006 through 

5 2010.’’. 

6 TITLE VI—AUTHORIZATIONS 

7 AND EXTENSION OF TERMI8 NATION DATE 

9 SEC. 601. AUTHORIZATION OF APPROPRIATIONS. 

10 Section 714 is amended— 

11 (1) by striking ‘‘title,’’ and inserting ‘‘title ex12 cept activities otherwise specified,’’; and 

13 (2) by striking ‘‘1999 through 2003’’ and in14 serting ‘‘2006 through 2010’’. 

15 SEC. 602. EXTENSION OF TERMINATION DATE. 

16 Section 715(a) is amended by striking ‘‘September 

17 30, 2003, this title and the amendments made by this 

18 title’’ and inserting ‘‘September 30, 2008, this title and 

19 the amendments made to this title’’. 

20 TITLE VII—ANTI-DOPING 

21 AGENCY 

22 SEC. 701. DESIGNATION OF UNITED STATES ANTI-DOPING 

23 AGENCY. 

24 (a) DEFINITIONS.—In this title: 

25 (1) UNITED STATES OLYMPIC COMMITTEE.— 

26 The term ‘‘United States Olympic Committee’’ 


ccoleman on PROD1PC71 with BILLS
62 

•S 2560 IS

1 means the organization established by the ‘‘Ted Ste2 vens Olympic and Amateur Sports Act’’ (36 U.S.C. 

3 220501 et seq.). 

4 (2) AMATEUR ATHLETIC COMPETITION.—The 

5 term ‘‘amateur athletic competition’’ means a con6 test, game, meet, match, tournament, regatta, or 

7 other event in which amateur athletes compete (36 

8 U.S.C. 220501(b)(2)). 

9 (3) AMATEUR ATHLETE.—The term ‘‘amateur 

10 athlete’’ means an athlete who meets the eligibility 

11 standards established by the national governing body 

12 or paralympic sports organization for the sport in 

13 which the athlete competes (36 U.S.C. 22501(b)(1)). 

14 (b) IN GENERAL.—The United States Anti-Doping 

15 Agency shall— 

16 (1) serve as the independent anti-doping organi17 zation for the amateur athletic competitions recog18 nized by the United States Olympic Committee; 

19 (2) ensure that athletes participating in ama20 teur athletic activities recognized by the United 

21 States Olympic Committee are prevented from using 

22 performance-enhancing drugs; 

23 (3) implement anti-doping education, research, 

24 testing, and adjudication programs to prevent 

25 United States Amateur Athletes participating in any 


ccoleman on PROD1PC71 with BILLS
63 

•S 2560 IS

1 activity recognized by the United States Olympic 

2 Committee from using performance-enhancing 

3 drugs; and 

4 (4) serve as the United States representative 

5 responsible for coordination with other anti-doping 

6 organizations coordinating amateur athletic competi7 tions recognized by the United States Olympic Com8 mittee to ensure the integrity of athletic competition, 

9 the health of the athletes and the prevention of use 

10 of performance-enhancing drugs by United States 

11 amateur athletes. 

12 SEC. 702. RECORDS, AUDIT, AND REPORT. 

13 (a) RECORDS.—The United States Anti-Doping 

14 Agency shall keep correct and complete records of account. 

15 (b) REPORT.—The United States Anti-Doping Agen16 cy shall submit an annual report to Congress which shall 

17 include— 

18 (1) an audit conducted and submitted in ac19 cordance with section 10101 of title 36, United 

20 States Code; and 

21 (2) a description of the activities of the agency. 

22 SEC. 703. AUTHORIZATION OF APPROPRIATIONS. 

23 There are authorized to be appropriated to the 

24 United States Anti-Doping Agency— 

25 (1) for fiscal year 2007, $9,700,000; 


ccoleman on PROD1PC71 with BILLS
64 

•S 2560 IS

1 (2) for fiscal year 2008, $10,300,000; 

2 (3) for fiscal year 2009, $10,600,000; 

3 (4) for fiscal year 2010, $11,000,000; and 

4 (5) for fiscal year 2011, $11,500,000. 

5 TITLE VIII—DRUG-FREE 

6 COMMUNITIES 

7 SEC. 801. REAUTHORIZATION. 

8 Section 1024(a) of the Drug-Free Communities Act 

9 of 1997 (21 U.S.C. 1524(a)) is amended— 

10 (1) in paragraph (9), by striking ‘‘and’’ after 

11 the semicolon; 

12 (2) in paragraph (10), by striking the period 

13 and inserting a semicolon; and 

14 (3) by adding at the end the following: 

15 ‘‘(11) $109,000,000 for fiscal year 2008; 

16 ‘‘(12) $119,000,000 for fiscal year 2009; 

17 ‘‘(13) $129,000,000 for fiscal year 2010; 

18 ‘‘(14) $139,000,000 for fiscal year 2011; and 

19 ‘‘(15) $149,000,000 for fiscal year 2012.’’. 

20 SEC. 802. SUSPENSION OF GRANTS. 

21 (a) IN GENERAL.—Section 1032(b) of the Drug-Free 

22 Communities Act of 1997 (21 U.S.C. 1532(b)) is amended 

23 by adding at the end the following: 

24 ‘‘(4) PROCESS FOR SUSPENSION.—A grantee 

25 shall not be suspended or terminated under paraVerDate Aug 31 2005 02:23 Apr 08, 2006 Jkt 049196 PO 00000 Frm 00064 Fmt 6652 Sfmt 6201 E:\BILLS\S2560.IS S2560

ccoleman on PROD1PC71 with BILLS
65 

•S 2560 IS

1 graph (1)(A)(ii), (2)(A)(iii), or (3)(E) unless that 

2 grantee is afforded a fair, timely, and independent 

3 appeal prior to such suspension or termination.’’. 

4 (b) REPORT TO CONGRESS.—Not later than 60 days 

5 after the date of enactment of this Act, the Director of 

6 the Office of National Drug Control Policy shall submit 

7 to Congress a report detailing the appeals process required 

8 by section 1032 (b)(4) of the Drug-Free Communities Act 

9 of 1997, as added by subsection (a). 

10 SEC. 803. GRANT AWARD INCREASE. 

11 Subsections (b)(1)(A)(iv), (b)(2)(C)(i), and (b)(3)(F) 

12 of section 1032 of the Drug-Free Communities Act of 

13 1997 (21 U.S.C. 1532) are amended by striking 

14 ‘‘$100,000’’ and inserting ‘‘$125,000’’. 

15 SEC. 804. PROHIBITION ON ADDITIONAL ELIGIBILITY CRI16 TERIA. 

17 Section 1032(a) of the Drug-Free Communities Act 

18 of 1997 (21 U.S.C. 1532(a)) is amended by adding at the 

19 end the following: 

20 ‘‘(7) ADDITIONAL CRITERIA.—The Director 

21 shall not impose any eligibility criteria on new appli22 cants or renewal grantees not provided in this chap23 ter.’’. 


ccoleman on PROD1PC71 with BILLS
66 

•S 2560 IS

1 SEC. 805. SUPPLEMENTAL GRANTS FOR COALITIONS. 

2 The Drug-Free Communities Act of 1997 (21 U.S.C. 

3 1521 et seq.) is amended by inserting after section 1035 

4 the following: 

5 ‘‘SEC. 1036. SUPPLEMENTAL GRANTS FOR COALITIONS 

6 WITH A MAJOR LOCAL DRUG CRISIS. 

7 ‘‘(a) AUTHORITY TO MAKE GRANTS.—As part of the 

8 program established under section 1031, the Director may 

9 award an initial grant under this subsection, and renewal 

10 grants under subsection (f), to any coalition awarded a 

11 grant under section 1032 that meets the criteria specified 

12 in subsection (d) in order to fund a coalition dealing with 

13 a major local drug crisis. 

14 ‘‘(b) TREATMENT WITH OTHER GRANTS.— 

15 ‘‘(1) SUPPLEMENT.—A grant awarded to a coa16 lition under this section is in addition to any grant 

17 awarded to the coalition under section 1032. 

18 ‘‘(2) REQUIREMENT FOR BASIC GRANT.—A coa19 lition may not be awarded a grant under this section 

20 for a fiscal year unless the coalition was awarded a 

21 grant or renewal grant under section 1032(b) for 

22 that fiscal year. 

23 ‘‘(c) APPLICATION.—A coalition seeking a grant 

24 under this section shall submit to the Administrator an 

25 application for the grant in such form and manner as the 

26 Administrator may require. 


ccoleman on PROD1PC71 with BILLS
67 

•S 2560 IS

1 ‘‘(d) CRITERIA.—A coalition meets the criteria speci2 fied in this subsection if the coalition— 

3 ‘‘(1) has achieved by or through it’s own efforts 

4 measurable results in the prevention and reduction 

5 of substance use among youth generally; 

6 ‘‘(2) has documented a highly, statistically sig7 nificant increase in a specific drug, from a baseline 

8 determined by locally collected data, that can be de9 fined as a local drug crisis; and 

10 ‘‘(3) submits to the Administrator a detailed 

11 plan for addressing the specific local drug crisis. 

12 ‘‘(e) USE OF GRANT FUNDS.—A coalition awarded 

13 a grant under this section shall use the grant amount for 

14 implementing comprehensive, community-wide strategies 

15 that address their local drug crises in accordance with the 

16 detailed plan submitted to the Administrator under sub17 section (d)(3). 

18 ‘‘(f) RENEWAL GRANTS.—The Administrator may 

19 make a renewal grant to any coalition awarded a grant 

20 under subsection (a), or a previous renewal grant under 

21 this subsection, if the coalition at the time of the applica22 tion for such renewal grant— 

23 ‘‘(1) continues to meet the criteria specified in 

24 subsection (d); and 


ccoleman on PROD1PC71 with BILLS
68 

•S 2560 IS

1 ‘‘(2) has made demonstrable progress in ad2 dressing the specific local drug crisis. 

3 ‘‘(g) GRANT AMOUNTS.— 

4 ‘‘(1) IN GENERAL.—Subject to paragraphs (2) 

5 and (3) the total amount of grants awarded to a co6 alition under this section for a fiscal year may not 

7 exceed the amount of non-Federal funds raised by 

8 the coalition, including in kind contributions, for 

9 that fiscal year. 

10 ‘‘(2) INITIAL GRANTS.—The amount of the ini11 tial grant awarded to a coalition under subsection 

12 (a) may not exceed $50,000. 

13 ‘‘(3) RENEWAL GRANTS.—The total amount of 

14 renewal grants awarded to a coalition under sub15 section (f) for any fiscal year may not exceed 

16 $50,000. 

17 ‘‘(h) FISCAL YEAR LIMITATION ON THE AMOUNT

18 AVAILABLE FOR GRANTS.—The total amount available for 

19 grants under this section, including renewal grants under 

20 subsection (f), in any fiscal year may not exceed the 

21 amount equal to 5 percent of the actual amount appro22 priated for that fiscal year.’’. 


ccoleman on PROD1PC71 with BILLS
69 

•S 2560 IS

1 SEC. 806. NATIONAL COMMUNITY ANTIDRUG COALITION IN2 STITUTE. 

3 Section 4 of Public Law 107–82 (21 U.S.C. 1521 

4 note), reauthorizing the Drug-Free Communities Support 

5 Program, is amended— 

6 (1) by amending subsection (a) to read as fol7 lows: 

8 ‘‘(a) IN GENERAL.—The Director of the Office of 

9 National Drug Control Policy shall, using amounts au10 thorized to be appropriated by subsection (d), make a di11 rected grant to Community Anti-Drug Coalitions of Amer12 ica to provide for the continuation of the National Com13 munity Antidrug Coalition Institute.’’; 

14 (2) by striking subsection (b) and redesignating 

15 subsections (c) and (d) as (b) and (c), respectively; 

16 and 

17 (3) in subsection (c), as redesignated by para18 graph (2), by adding at the end the following: 

19 ‘‘(4) For each of the fiscal years 2008 through 

20 2012, $2,000,000.’’. 

21 SEC. 807. CONTRACTING REQUIREMENT. 

22 Section 1031(d) of the Drug-Free Communities Act 

23 of 1997 (21 U.S.C. 1531(d)) is amended by adding at the 

24 end the following: ‘‘The Director shall delegate all author25 ity for grant eligibility determinations, review, selection, 


ccoleman on PROD1PC71 with BILLS
70 

•S 2560 IS

1 management, and appeals to another qualified national 

2 drug control agency.’’. 

3 TITLE IX—NATIONAL GUARD 

4 COUNTERDRUG SCHOOLS 

5 SEC. 901. NATIONAL GUARD COUNTERDRUG SCHOOLS. 

6 (a) AUTHORITY TO OPERATE.—Under such regula7 tions as the Secretary of Defense may prescribe, the Chief 

8 of the National Guard Bureau may establish and operate, 

9 or provide financial assistance to the States to establish 

10 and operate, not more than five schools (to be known gen11 erally as ‘‘National Guard counterdrug schools’’). 

12 (b) PURPOSE.—The purpose of the National Guard 

13 counterdrug schools shall be the provision by the National 

14 Guard of training in drug interdiction and counterdrug 

15 activities and drug demand reduction activities to per16 sonnel of the following: 

17 (1) Federal agencies. 

18 (2) State and local law enforcement agencies. 

19 (3) Community-based organizations engaged in 

20 such activities. 

21 (4) Other non-Federal governmental and pri22 vate entities and organizations engaged in such ac23 tivities. 


ccoleman on PROD1PC71 with BILLS
71 

•S 2560 IS

1 (c) COUNTERDRUG SCHOOLS SPECIFIED.—The Na2 tional Guard counterdrug schools operated under the au3 thority in subsection (a) are as follows: 

4 (1) The National Interagency Civil-Military In5 stitute (NICI), San Luis Obispo, California. 

6 (2) The Multi-Jurisdictional Counterdrug Task 

7 Force Training (MCTFT), St. Petersburg, Florida. 

8 (3) The Midwest Counterdrug Training Center 

9 (MCTC), Johnston, Iowa. 

10 (4) The Regional Counterdrug Training Acad11 emy (RCTA), Meridian, Mississippi. 

12 (5) The Northeast Regional Counterdrug Train13 ing Center (NCTC), Fort Indiantown Gap, Pennsyl14 vania. 

15 (d) USE OF NATIONAL GUARD PERSONNEL.— 

16 (1) IN GENERAL.—To the extent provided for 

17 in the State drug interdiction and counterdrug ac18 tivities plan of a State in which a National Guard 

19 counterdrug school is located, personnel of the Na20 tional Guard of that State who are ordered to per21 form full-time National Guard duty authorized 

22 under section 112(b) of that title 32, United States 

23 Code, may provide training referred to in subsection 

24 (b) at that school. 


ccoleman on PROD1PC71 with BILLS
72 

•S 2560 IS

1 (2) DEFINITION.—In this subsection, the term 

2 ‘‘State drug interdiction and counterdrug activities 

3 plan’’, in the case of a State, means the current plan 

4 submitted by the Governor of the State to the Sec5 retary of Defense under section 112 of title 32, 

6 United States Code. 

7 (e) TREATMENT UNDER AUTHORITY TO PROVIDE

8 COUNTERDRUG SUPPORT.—The provisions of section 

9 1004 of the National Defense Authorization Act for Fiscal 

10 Year 1991 (Public Law 101–510; 10 U.S.C. 374 note) 

11 shall apply to any activities of a National Guard 

12 counterdrug school under this section that are for an 

13 agency referred to in subsection (a) of such section 1004 

14 and for a purpose set forth in subsection (b) of such sec15 tion 1004. 

16 (f) ANNUAL REPORTS ON ACTIVITIES.— 

17 (1) IN GENERAL.—Not later than February 1 

18 each year, the Secretary of Defense shall submit to 

19 Congress a report on the activities of the National 

20 Guard counterdrug schools during the preceding 

21 year. 

22 (2) CONTENTS.—Each report under paragraph 

23 (1) shall set forth the following: 

24 (A) FUNDING.—The amount made avail25 able for each National Guard counterdrug 


ccoleman on PROD1PC71 with BILLS
73 

•S 2560 IS

1 school during the fiscal year ending in the year 

2 preceding the year in which such report is sub3 mitted. 

4 (B) ACTIVITIES.—A description of the ac5 tivities of each National Guard counterdrug 

6 school during the year preceding the year in 

7 which such report is submitted. 

8 (g) AUTHORIZATION OF APPROPRIATIONS.— 

9 (1) IN GENERAL.—There is hereby authorized 

10 to be appropriated for the Department of Defense 

11 for the National Guard for each of fiscal years 2006 

12 through 2010, $30,000,000 for purposes of the Na13 tional Guard counterdrug schools in such fiscal year. 

14 (2) CONSTRUCTION.—The amount authorized 

15 to be appropriated by paragraph (1) for a fiscal year 

16 is in addition to any other amount authorized to be 

17 appropriated for the Department of Defense for the 

18 National Guard for such fiscal year. 

19 TITLE X—MISCELLANEOUS 

20 PROVISIONS 

21 SEC. 1001. REPEALS. 

22 (a) ACT.—Sections 709, 710, and 711 are repealed. 

23 (b) FORFEITURE ASSETS.—Section 6073 of the As24 sets Forfeiture Amendments Act of 1988 (21 U.S.C. 

25 1509) is repealed. 


ccoleman on PROD1PC71 with BILLS
74 

•S 2560 IS

1 SEC. 1002. CONTROLLED SUBSTANCES ACT AMENDMENTS. 

2 Section 303(g)(2)(B)(iii) of the Controlled Sub3 stances Act (21 U.S.C. 823(g)(2)(B)(iii)) is amended by 

4 striking ‘‘except that the Secretary’’ and inserting the fol5 lowing: ‘‘unless, not sooner than 1 year after the date on 

6 which the practitioner submitted the initial notification, 

7 the practitioner submits a second notification to the Sec8 retary of the need and intent of the practitioner to treat 

9 more than such applicable number of patients. A second 

10 notification under this clause shall contain the certifi11 cations required by clauses (i) and (ii) of this subpara12 graph. The Secretary’’. 

13 SEC. 1003. REPORT ON INTELLIGENCE SHARING. 

14 Not later than 180 days after the date of enactment 

15 of this Act, the Director shall submit to Congress a re16 port— 

17 (1) evaluating existing and planned intelligence 

18 systems used by Federal, State, and local law en19 forcement agencies responsible for drug trafficking 

20 and drug production enforcement; and 

21 (2) addressing— 

22 (A) the current intelligence systems used 

23 by Federal, State, and local law enforcement 

24 agencies; 


ccoleman on PROD1PC71 with BILLS
75 

•S 2560 IS

1 (B) the compatibility of such systems in 

2 ensuring access and availability of intelligence 

3 to Federal, State, and local law enforcement; 

4 (C) the extent to which Federal, State, and 

5 local law enforcement are sharing intelligence 

6 information to assess current threats and de7 sign appropriate enforcement strategies; and 

8 (D) the measures needed to ensure and to 

9 promote effective information sharing among 

10 intelligence systems operated by Federal, State, 

11 and local law enforcement agencies responsible 

12 for drug trafficking and drug production en13 forcement. 

14 SEC. 1004. REQUIREMENT FOR SOUTH AMERICAN HEROIN 

15 STRATEGY. 

16 (a) IN GENERAL.—Not later than 90 days after the 

17 date of enactment of this Act, the Director shall submit 

18 to Congress a comprehensive strategy that addresses the 

19 increased threat from South American heroin, and in par20 ticular Colombian heroin, and the emerging threat from 

21 opium poppy grown in Peru and often intended for transit 

22 to Columbia for processing into heroin. 

23 (b) CONTENTS.—The strategy submitted under sub24 section (a) shall include— 


ccoleman on PROD1PC71 with BILLS
76 

•S 2560 IS

1 (1) opium eradication efforts to eliminate the 

2 problem at the source to prevent heroin from enter3 ing the stream of commerce; 

4 (2) interdiction and precursor chemical con5 trols; 

6 (3) demand reduction and treatment; 

7 (4) alternative development programs, including 

8 direct assistance to regional governments to demobi9 lize and provide alternative livelihoods to former 

10 members of insurgent or other groups engaged in 

11 heroin, cocoa, or other illicit drug production or traf12 ficking; 

13 (5) efforts to inform and involve local citizens 

14 in the programs described in paragraphs (1) through 

15 (4), such as through leaflets advertising rewards for 

16 information; 

17 (6) provisions that ensure the maintenance at 

18 current levels of efforts to eradicate coca in Colom19 bia; and 

20 (7) an assessment of the specific level of fund21 ing and resources necessary to simultaneously ad22 dress the threat from South American heroin and 

23 the threat from Colombian and Peruvian coca. 

24 (c) TREATMENT OF CLASSIFIED OR LAW ENFORCE25 MENT SENSITIVE INFORMATION.—Any content of the 


ccoleman on PROD1PC71 with BILLS
77 

•S 2560 IS

1 strategy submitted under subsection (a) that involves in2 formation classified under criteria established by an Exec3 utive order, or whose public disclosure, as determined by 

4 the Director or the head of any relevant Federal agency, 

5 would be detrimental to the law enforcement of national 

6 security activities of any Federal, foreign, or international 

7 agency, shall be presented to Congress separately from the 

8 rest of the strategy. 

9 SEC. 1005. MODEL ACTS. 

10 (a) IN GENERAL.—The Director shall enter into an 

11 agreement with a nonprofit corporation that works with 

12 States on laws and policies to address alcohol and other 

13 drug issues, under which the corporation shall revise the 

14 model State drug laws developed by the President’s Com15 mission on Model State Drug Laws and draft supple16 mentary model acts to meet changes in States’ substance 

17 abuse issues. 

18 (b) AUTHORIZATION OF APPROPRIATIONS.—There 

19 are authorized to be appropriated $1,500,000 to carry out 

20 this section. 

Æ 


ccoleman on PROD1PC71 with BILLS